Xeris Biopharma Holdings Inc (XERS)
EBITDA
-$20.94M
Quarterly · Period ending: · USD
XERS EBITDA
Latest reported-$20.94Mperiod ending
Latest reported-$20.94Mperiod ending
XERS Quarterly EBITDA (-$4.61M → -$20.94M)
Quarterly EBITDA
High-resolution chart · PNG
XERS ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -20,944,000 | |
| 12,328,000 | |
| 14,127,000 | |
| 11,078,000 | |
| 8,594,000 | |
| 1,228,000 | |
| 5,723,000 | |
| -8,152,000 | |
| -3,138,000 | |
| -8,427,000 | |
| -3,349,000 | |
| -2,323,000 | |
| -10,626,000 | |
| -7,437,000 | |
| -5,398,000 | |
| -15,110,000 | |
| -20,014,000 | |
| -27,569,000 | |
| -48,095,000 | |
| -23,888,000 | |
| -25,400,000 | |
| -16,283,000 | |
| -16,820,000 | |
| -13,289,000 | |
| -21,649,000 | |
| -27,365,000 | |
| -31,629,000 | |
| -28,990,000 | |
| -33,098,000 | |
| -24,080,000 | |
| -19,190,000 | |
| -14,025,000 | |
| -12,347,000 | |
| -11,653,000 | |
| -9,091,000 | |
| -7,520,000 | |
| -5,166,000 | |
| -4,611,000 |